Dulozafone

CAS No. 75616-02-3

Dulozafone( —— )

Catalog No. M36160 CAS No. 75616-02-3

Dulozafone (F1933) has an anti- showed anticonvulsant activity in a brain amygdala ignition model and protected fully ignited rats from generalized seizures.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 290 Get Quote
5MG 456 Get Quote
10MG 653 Get Quote
25MG 994 Get Quote
50MG 1362 Get Quote
100MG 1791 Get Quote
500MG 3528 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dulozafone
  • Note
    Research use only, not for human use.
  • Brief Description
    Dulozafone (F1933) has an anti- showed anticonvulsant activity in a brain amygdala ignition model and protected fully ignited rats from generalized seizures.
  • Description
    Dulozafone (F1933) has an anti- showed anticonvulsant activity in a brain amygdala ignition model and protected fully ignited rats from generalized seizures.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    75616-02-3
  • Formula Weight
    425.31
  • Molecular Formula
    C20H22Cl2N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C1=C(N(C(CN(CCO)CCO)=O)C)C=CC(Cl)=C1)C2=C(Cl)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Vasoactive Intestina...

    Vasoactive Intestinal Contractor [VIC]

  • Coleneuramide

    Coleneuramide (MCC-257) enhances the effect of nerve growth factor (NGF) on cell survival and can be used to study diabetic polyneuropathy.

  • Monomethyl lithosper...

    Monomethyl lithospermate has potential antiviral activity, alleviating ischemic stroke injury in vivo in middle cerebral artery occlusion mice by activating PI5K/Akt signaling and protecting oxygen-glucose deprivation/reoxygenation-induced SHSY-3Y cells in vitro.